EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Combining Low-Dose Computer-Tomography-Based Radiomics and Serum Metabolomics for Diagnosis of Malignant Nodules in Participants of Lung Cancer Screening Studies

Joanna Zyla iD, Michal Marczyk iD, Wojciech Prazuch, Magdalena Sitkiewicz, Agata Durawa, Malgorzata Jelitto, Katarzyna Dziadziuszko, Karol Jelonek iD, Agata Kurczyk iD, Edyta Szurowska iD, Witold Rzyman, Piotr Widłak iD und 1 weitere

Biomolecules · 28.12.2023 · 14 (1) · 44

DOI: 10.3390/biom14010044 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, online erschienen am 28.12.2023. Verfasst von Joanna Zyla und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Data Science and Engineering, Silesian University of Technology, 44-100 Gliwice, Poland. Hauptthemen laut MEDLINE: Early Detection of Cancer, Lung Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Center, Silesian University of Technology, National Science Centre, Poland, OPUS program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Radiomics is an emerging approach to support the diagnosis of pulmonary nodules detected via low-dose computed tomography lung cancer screening. Serum metabolome is a promising source of auxiliary biomarkers that could help enhance the precision of lung cancer diagnosis in CT-based screening. Thus, we aimed to verify whether the combination of these two techniques, which provides local/morphological and systemic/molecular features of disease at the same time, increases the performance of lung cancer classification models. The collected cohort consists of 1086 patients with radiomic and 246 patients with serum metabolomic evaluations. Different machine learning techniques, i.e., random forest and logistic regression were applied for each omics. Next, model predictions were combined with various integration methods to create a final model. The best single omics models were characterized by an AUC of 83% in radiomics and 60% in serum metabolomics. The model integration only slightly increased the performance of the combined model (AUC equal to 85%), which was not statistically significant. We concluded that radiomics itself has a good ability to discriminate lung cancer from benign lesions. However, additional research is needed to test whether its combination with other molecular assessments would further improve the diagnosis of screening-detected lung nodules.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Early Detection of CancerLung NeoplasmsHumansRadiomicsTomography, X-Ray ComputedComputers

Stichwörter der Autor:innen

classification modelsearly detectionintegrationlung cancerscreening study

Autor:innen und Institutionen

  • Department of Data Science and Engineering, Silesian University of Technology, 44-100 Gliwice, Poland.
  • Yale Cancer Center, Yale School of Medicine, New Haven, CT 06510, USA.
  • Department of Thoracic Surgery, Medical University of Gdansk, 80-210 Gdansk, Poland.
  • 2nd Department of Radiology, Medical University of Gdansk, 80-210 Gdansk, Poland.
  • Center for Translational Research and Molecular Biology of Cancer, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-100 Gliwice, Poland.
  • Department of Biostatistics and Bioinformatics, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-100 Gliwice, Poland.

ORCID-Profile: Joanna Zyla, Michal Marczyk, Karol Jelonek, Agata Kurczyk, Edyta Szurowska, Piotr Widłak, Joanna Polanska

Förderung

  • National Science Center
  • Silesian University of Technology
  • National Science Centre, Poland, OPUS program
  • project MOLTEST-BIS

Zitieren

APA

Zyla, J., Marczyk, M., Prazuch, W., Sitkiewicz, M., Durawa, A., Jelitto, M., Dziadziuszko, K., Jelonek, K., Kurczyk, A., Szurowska, E., Rzyman, W., Widłak, P., & Polanska, J. (2023). Combining Low-Dose Computer-Tomography-Based Radiomics and Serum Metabolomics for Diagnosis of Malignant Nodules in Participants of Lung Cancer Screening Studies. Biomolecules, 14(1), 44. https://doi.org/10.3390/biom14010044

Vancouver

Zyla J, Marczyk M, Prazuch W, Sitkiewicz M, Durawa A, Jelitto M, et al. Combining Low-Dose Computer-Tomography-Based Radiomics and Serum Metabolomics for Diagnosis of Malignant Nodules in Participants of Lung Cancer Screening Studies. Biomolecules. 2023;14(1):44. doi:10.3390/biom14010044

BibTeX
@article{Zyla2023,
  author = {Zyla, Joanna and Marczyk, Michal and Prazuch, Wojciech and Sitkiewicz, Magdalena and Durawa, Agata and Jelitto, Malgorzata and Dziadziuszko, Katarzyna and Jelonek, Karol and Kurczyk, Agata and Szurowska, Edyta and Rzyman, Witold and Widłak, Piotr and Polanska, Joanna},
  title = {Combining Low-Dose Computer-Tomography-Based Radiomics and Serum Metabolomics for Diagnosis of Malignant Nodules in Participants of Lung Cancer Screening Studies},
  journal = {Biomolecules},
  year = {2023},
  volume = {14},
  number = {1},
  pages = {44},
  doi = {10.3390/biom14010044}
}
Kostenlos starten →